BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

Netildex® (dexamethasone with netilmicin) for local treatment of eye inflammation and bacterial infection Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use - 6th ed. (2016) Methylphenidate hydrochloride long-acting (modified-release) preparations: caution if switching between products due to differences in formulations

Paclitaxel formulations (conventional and nab-paclitaxel): caution required due to potential for medication error We may be able to source and supply a paper copy in exceptional circumstances, from surplus BNFs distributed to other parts of the NHS. Please register your interest in receiving a copy via the online form at: https://www.snapsurveys.com/wh/s.asp?k=153553886772 Ideal for use by Pharmacists, Chemists, Nurses and Doctors within Hospitals, Nursing Homes, Pharmacies and Hospices and the ideal reference tool for all Care and support staff. See also:

British National Formulary (BNF) Product Details:

Chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions Ivacaftor, tezacaftor, elexacaftor (Kaftrio®▼) in combination with ivacaftor (Kalydeco®): risk of serious liver injury; updated advice on liver function testing Ducressa® (dexamethasone with levofloxacin)for prophylaxis or treatment of postoperative inflammation, or prevention of infection, following cataract surgery The British National Formulary (BNF) is a book that is published twice a year in March and September. Compiled with the advice of clinical experts, its an essential reference providing up to date guidance on the prescribing, dispensing and administration of medicines. British National Formulary (BNF) Product Details: Paper copies were historically distributed yearly, each October. The digital versions will take over from this October 2018.

Authoritative, independent guidance on best practice enabling you to select safe and effective medicinesBrolucizumab (Beovu®): updated recommendations to minimise the known risk of intraocular inflammation, including retinal vasculitis and/or retinal vascular occlusion Maximum daily doses added for colecalciferol and ergocalciferol in the treatment of vitamin D deficiency Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) The British National Formulary (BNF) is the first choice for concise medicines information. Trusted by health professionals across the world to support confident decision-making at the point of care.

Dexmedetomidine: clinical trial finds increased risk of mortality in intensive care unit patients aged 65 years or youngerHydroxychloroquine sulfate: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions Biologics, Biosimilars and Biobetters: An Introduction for Pharmacists, Physicians and other Health Practitioners(2021) Haloperidol (Haldol®): reminder of risks when used in elderly patients for the acute treatment of delirium

Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists The new edition (BNF 85) provides up-to-date guidance on prescribing, dispensing, and administering medicines, plus legal and professional guidelines. Our opening hours are from 9 am till 5 pm Monday to Thursday and 8:30 am till 4:30 pm on Fridays. You may also like…

Potassium permanganate: inadvertent oral administration of potassium permanganate [National Patient Safety Alert advice] Amiodarone hydrochloride (Cordarone X®): reminder of risks of treatment and need for patient monitoring and supervision